Evolving treatment strategies for chronic refractory angina

Expert Opinion on Pharmacotherapy

Volumn 7, Issue 3, 2006, Pages 259-266

  Yang, Eric H ^a   Barsness, Gregory W ^a  

^a Mayo Clinic   (United States)

Author keywords

Counter pulsation; Refractory angina; Spinal stimulation; Therapy

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATASE; AMLODIPINE; ARGININE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DILTIAZEM; FATTY ACID DERIVATIVE; IVABRADINE; NICORANDIL; NITRATE; NITRIC OXIDE; OXYGEN; PLACEBO; POTASSIUM CHANNEL; RANOLAZINE; SODIUM CHANNEL; TICLOPIDINE; TRIMETAZIDINE; VASCULOTROPIN;

ANGINA PECTORIS; ASTHENIA; BLOATING; BRADYCARDIA; BURNING SENSATION; CLINICAL TRIAL; CONSTIPATION; COUNTERPULSATION; DIZZINESS; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEADACHE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; HYPERKALEMIA; HYPOTENSION; LIVER METABOLISM; META ANALYSIS; NAUSEA; QT PROLONGATION; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SPINAL CORD STIMULATION; ST SEGMENT DEPRESSION; STRUCTURE ACTIVITY RELATION; SYMPTOM; SYSTEMATIC REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION; VISUAL DISORDER;

ACETANILIDES; ANGINA PECTORIS; ARGININE; BENZAZEPINES; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; COUNTERPULSATION; ELECTRIC STIMULATION THERAPY; HUMANS; MYOCARDIAL REVASCULARIZATION; PIPERAZINES; RANDOMIZED CONTROLLED TRIALS; SPINAL CORD;

EID: 33144456576     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.7.3.259     Document Type: Review

References (57)

1. MANNHEIMER C, CAMICI P, CHESTER MR et al.: The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur. Heart J. (2002) 23(5):355-370.
2. YANG EH, BARSNESS GW, GERSH BJ, CHANDRASEKARAN K, LERMAN A: Current and future treatment strategies for refractory angina. Mayo Clin. Proc. (2004) 79(10):1284-1292.
3. THADANI U: Current medical management of chronic stable angina. J. Cardiovasc. Pharmacol. Ther. (2004) 9(Suppl. 1):S11-S29.
4. EGASHIRA K, HIROOKA Y, KUGA T, MOHRI M, TAKESHITA A: Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation (1996) 94(2):130-134.
5. CEREMUZYNSKI L, CHAMIEC T, HERBACZYNSKA-CEDRO K: Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am. J. Cardiol. (1997) 80(3):331-333.
6. BOIS P, BESCOND J, RENAUDON B, LENFANT J: Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br. J. Pharmacol. (1996) 118(4):1051-1057.
7. BORER JS, FOX K, JAILLON P, LEREBOURS G, FOR THE IVABRADINE INVESTIGATORS GROUP: Antianginal and antiischemic effects of ivabradine, an if inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation (2003) 107(6):817-823.
8. TARDIF J: INITIATIVE trial. Presented at ESC Congress 2003 Vienna (2003).
9. BELARDINELLI L, ANTZELEVITCH C, FRASER H: Inhibition of the late sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and it detrimental effects on cardiomyocyte function. Eur. Heart J. (2004) 6(Suppl. 1):13-17.
10. Na in guinea pig ventricular myocytes. J. Cardiovasc. Pharmacol. (2004) 44:192-199.
11. CHAITMAN BR, SKETTINO SL, PARKER JO et al.: Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J. Am. Coll. Cardiol. (2004) 43(8):1375-1382.
12. CHAITMAN BR, PEPINE CJ, PARKER JO et al.: Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA (2004) 291(3):309-316.
13. MARKHAM A, PLOSKER GL, GOA KL: Nicorandil: an updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs (2000) 60(4):955-974.
14. CIAMPRICOTTI R, SCHOTBORGH CE, DE KAM PJ, VAN HERWAARDEN RH: A comparison of nicorandil with isosorbide mononitrate in elderly patients with stable coronary heart disease: the SNAPE study. Am. Heart J. (2000) 139(5):939-943.
15. DI SOMMA S, LIGUORI V, PETITTO M: A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris. Cardiovasc. Drugs Ther. (1993) 7:119-123.
16. MEETER K, KELDER JC, TIJSSEN JG et al.: Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study. J. Cardiovasc. Pharmacol. (1992) 20(Suppl. 3):S59-S66.
17. RAFTERY EB, LAHIRI A, HUGHES LO, ROSE EL: A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina. Eur. Heart J. (1993) 14(Suppl. B):35-39.
18. YAMAZAKI J, IIDA M, IGARASHI M et al.: Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT. Int. J. Clin. Pharmacol. Ther. (1994) 32:183-191.
19. STANLEY WC, MARZILLI M: Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine. Fundam. Clin. Pharmacol. (2003) 17(2):133-145.
20. MARZILLI M, KLEIN WW: Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials. Coron. Artery Dis. (2003) 14(2):171-179.
21. MICHAELS AD, ACCAD M, PORTS TA, GROSSMAN W: Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation (2002) 106(10):1237-1242.
22. BONETTI PO, BARSNESS GW, KEELAN PC et al.: Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J. Am. Coll. Cardiol. (2003) 41(10):1761-1768.
23. KERSTEN JR, PAGEL PS, CHILIAN WM, WARLTIER DC: Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc. Res. (1999) 43(1):44-57.
24. ARORA RR, CHOU TM, JAIN D et al.: The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J. Am. Coll. Cardiol. (1999) 33(7):1833-1840.
25. ZHENG Z-S, LI T-M, KAMBIC H et al.: Sequential extrenal counterpulsation (SECP) in China. Trans. Am. Soc. Artif. Intern. Organs (1983) 29:599-603.
26. LAWSON WE, HUI JC, SOROFF HS et al.: Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am. J. Cardiol. (1992) 70(9):859-862.
27. LAWSON WE, HUI JC, ZHENG ZS et al.: Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology (1996) 87(4):271-275.
28. LAWSON WE, HUI JC, ZHENG SZ et al.: Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation? Am. J. Cardiol (1996) 77(12):1107-1109.
29. LAWSON WE, HUI JC, GUO T, BURGER L, COHN PF: Prior revascularisation increases the effectiveness of enhanced external counterpulsation. Clin. Cardiol. (1998) 21(11):841-844.
30. LAWSON WE, HUI JC, COHN PF: Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin. Cardiol. (2000) 23(4):254-258.
31. URANO H, IKEDA H, UENO T et al.: Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J. Am. Coll. Cardiol. (2001) 37(1):93-99.
32. 13N-ammonia positron emission tomography. Eur. Heart J. (2001) 22(16):1451-1458.
33. STYS T, LAWSON WE, HUI JC et al.: Acute hemodynamic effects and angina improvement with enhanced external counterpulsation. Angiology (2001) 52(10):653-658.
34. BARSNESS G, FELDMAN AM, HOLMES DR Jr et al.: The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin. Cardiol. (2001) 24(6):435-442.
35. STYS TP, LAWSON WE, HUI JC et al.: Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am. J. Cardiol. (2002) 89(7):822-824.
36. GIBBONS RJ, ABRAMS J, CHATTERJEE K et al.: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J. Am. Coll. Cardiol. (2003) 41(1):159-168.
37. MANNHEIMER C, AUGUSTINSSON LE, CARLSSON CA, MANHEM K, WILHELMSSON C: Epidural spinal electrical stimulation in severe angina pectoris. Br. Heart J. (1988) 59(1):56-61.
38. ELIASSON T, JERN S, AUGUSTINSSON LE, MANNHEIMER C: Safety aspects of spinal cord stimulation in severe angina pectoris. Coron. Artery Dis. (1994) 5(10):845-850.
39. JONGSTE MJ, HAAKSMA J, HAUTVAST RW et al.: Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocardiographic study. Br. Heart J. (1994) 71(5):413-418.
40. MANNHEIMER C, ELIASSON T, ANDERSSON B et al.: Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. Br. Med. J. (1993) 307(6902):477-480.
41. HAUTVAST RW, BROUWER J, DEJONGSTE MJ, LIE KI: Effect of spinal cord stimulation on heart rate variability and myocardial ischemia in patients with chronic intractable angina pectoris - a prospective ambulatory electrocardiographic study. Clin. Cardiol. (1998) 21(1):33-38.
42. ANDERSEN C, HOLE P, OXHOJ H: Does pain relief with spinal cord stimulation for angina conceal myocardial infarction? Br. Heart J. (1994) 71(5):419-421.
43. DE JONGSTE MJ, HAUTVAST RW, HILLEGE HL, LIE KI: Efficacy of spinal cord stimulation as adjuvant therapy for intractahle angina pectoris: a prospective, randomized clinical study. Working Group on Neurocardiology. J. Am. Coll. Cardiol. (1994) 23(7):1592-1597.
44. HAUTVAST RW, DEJONGSTE MJ, STAAL MJ, VAN GILST WH, LIE KI: Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study. Am. Heart J. (1998) 136(6):1114-1120.
45. TENVAARWERK IA, JESSURUN GA, DEJONGSTE MJ et al.: Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris. Heart (1999) 82(1):82-88.
46. MANNHEIMER C, ELIASSON T, AUGUSTINSSON L-E et al.: Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study. Circulation (1998) 97(12):1157-1163.
47. GOLDMAN A, GREENSTONE SM, PREUSS FS, STRAUSS SH, CHANG ES: Experimental methods for producing a collateral circulation to the heart directly from the left ventride. J. Thorac. Surg. (1956) 31:364-374.
48. OKADA M, IKUTA H, SHIMIZU K, HORII H, NAKAMURA K: Alternatives method of myocardial revascularization by laser: experimental and clinical study. Kobe J. Med. Sci. (1986) 32(5):151-161.
49. COOLEY DA, FRAZIER OH, KADIPASAOGLU KA et al.: Transmyocardial laser revascularization: anatomic evidence of long-term channel patency. Tex. Heart Inst. J. (1994) 21(3):220-224.
50. HARDY RI, BOVE KE, JAMES FW, KAPLAN S, GOLDMAN L: A histologic study of laser-induced transmyocardial channels. Lasers Surg. Med. (1987) 6(6):563-573.
51. KWONG KF, KANELLOPOULOS GK, NICKOLS JC et al.: Transmyocardial laser treatment denervates canine myocardium. J. Thorac. Cardiovasc. Surg. (1997) 114(6):883-890.
52. ALLEN KB, DOWLING RD, FUDGE TL et al.: Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N. Engl. J. Med. (1999) 341(14):1029-1036.
53. FRAZIER OH, MARCH RJ, HORVATH KA: Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N. Engl. J. Med. (1999) 341(14):1021-1028.
54. SCHOFIELD PM, SHARPLES LD, CAINE N et al.: Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet (1999) 353(9152):519-524.
55. BURKHOFF D, SCHMIDT S, SCHULMAN SP et al.: Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. Lancet (1999) 354(9182):885-890.
56. AABERGE L, NORDSTRAND K, DRAGSUND M et al.: Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris: clinical results from The Norwegian Randomized Trial. J. Am. Coll. Cardiol. (2000) 35(5):1170-1177.
57. JONES JW, SCHMIDT SE, RICHMAN BW et al.: Holmium:YAG laser transmyocardial revascularization relieves angina and improves functional status. Ann. Thorac. Surg.(1999) 67(6):1596-1601; discussion 1601-1602.